MENU
PYPD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
PolyPid (PYPD) Ownership - Who owns PolyPid?
Profile
Industry
N/A
Address
18 Hasivim Street
Phone
+972 747195700
Employees
62
Web
https://www.polypid.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
21.91M
P/E Ratio
N/A
Total Cash
9.53M
Projected Growth
N/A
Total Debt
10.02M
Revenue
N/A
Risk (Beta)
1.59
Dividend Yield
N/A
Total Cash/Share
1.40
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
PYPD
Capitalization
21.9M
P/E Ratio
N/A
Risk (Beta)
1.59
Dividend Yield
N/A
Total Cash
9.53M
Total Cash/Share
1.40
Total Debt
10M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
2.16M
P/B Ratio
10.15
Cash Flow
N/A
Earnings
-7.22
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
1.00
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-25.12M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-132.55
Shares Held By Institutions
6.7M
Shares Outstanding - Current
6.8M
Total Liabilities
17.4M
Total Volume MTD
N/A
Value
-1
Gain YTD
-15.263
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
18 Hasivim Street
Phone
+972 747195700
Employees
62
Web
https://www.polypid.com